Synthetic approaches to the 2014 new drugs

Andrew C Flick¹, Hong X Ding², Carolyn A Leverett¹

¹Pfizer Worldwide Research and Development, Groton Laboratories, 445 Eastern Point Road, Groton, CT 06340, United States.

|March 30, 2016

Abstract:

New drugs introduced to the market every year represent privileged structures for particular biological targets. These new chemical entities (NCEs) provide insight into molecular recognition and also serve as leads for designing future new drugs. This annual review covers the synthesis of thirty-seven NCEs that were approved for the first time in 2014 and one drug which was approved in 2013 and was not covered in a previous edition of this review.

Keywords:

Medicine New chemical entities New drug molecules Synthesis Therapeutic agents

Related Experiment Videos

Synthetic approaches to the 2014 new drugs

Related Concept Videos

Synthetic Approaches to the New Drugs Approved During 2024.

Synthetic Approaches to the New Drugs Approved during 2023.

Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1.

Synthetic Approaches to the New Drugs Approved During 2022.

Synthetic Approaches to the New Drugs Approved During 2021.

Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonists.

A novel ring-opened ebselen scaffold with potent anti-angiogenic activity against cancer: synthesis, biological evaluation, and molecular docking.

Design, synthesis, and biological evaluation of novel phenylindole derivatives as P-gp inhibitors to overcome multidrug resistance in MCF-7/ADR cells.

Striking two targets with one scaffold via benzo[d]imidazole-isatin conjugates as potent dual VEGFR-2/c-MET antagonists.

Development of covalent agonists for the muscarinic acetylcholine receptor.

Cancer cell membrane-coated superparamagnetic iron oxide nanoparticles as a theranostic platform for magnetic hyperthermia and MR imaging.

Evaluating the outputs of ARAE-based molecular generative model for synthetic accessibility and BTK inhibition.

Structure prediction and drug screening targeting monkeypox virus polymerase and surface proteins.

Discovery, validation, and mechanistic investigation of 5-fluorobenzothiazol-2-amine as a potential lead compound for pre-emergence herbicide development.

Design, synthesis, antifungal activity and preliminary mechanistic study of benzimidazole-containing cinnamamide derivatives against phytopathogenic fungi.

6-(2-Hydroxybenzoyl)pyrazolo[1,5-a]pyrimidine-3‑carbonitriles as novel reactive oxygen species-generating anticancer agents inducing ER stress and DNA damage in EGFR-mutant non-small cell lung cancer.

Online proteolysis and specific affinity enrichment of ACE inhibitory peptides on a magnetic nanoplatform from Torreya grandis protein.

Comparative phytochemical profiling of three medicinal Polygonaceae plants using integrated molecular networking and SIRIUS-guided annotation: Implications for chemotaxonomy.

Related Experiment Videos

Synthetic approaches to the 2014 new drugs

Abstract:

Related Concept Videos

Related Articles